The emerging cardioinhibitory role of the hippocampal cholinergic neurostimulating peptide

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 1, 2006, Pages 336-344

  Angelone, Tommaso ^a,b   Goumon, Yannick ^b   Cerra, Maria Carmela ^a   Metz Boutigue, Marie Hélène ^b   Aunis, Dominique ^b   Tota, Bruno ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY PRESSURE; DRUG EFFECT; HEART FUNCTION; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; MALE; MYOCARDIAL CONTRACTION; NEUROPEPTIDES; RATS; RATS, WISTAR; STIMULATION, CHEMICAL;

EID: 33745247194     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.102103     Document Type: Article

References (32)

1. Agnati LF, Tarakanov AO, and Guidolin D (2005) A simple mathematical model of cooperativity in receptor mosaics based on the "symmetry rule". Biosystems 80:165-173.
2. Brodde O-E, Bruck H, Leineweber K, and Seyfarth T (2001) Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528-538.
3. Casadei B and Sears CE (2003) Nitric-oxide-mediated regulation of cardiac contractility and stretch responses. Prog Biophys Mol Biol 82:67-80.
4. Cerra MC, De Iuri L, Angelone T, Corti A, and Tota B (2005) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function on the Langendorff-perfused rat heart. Basic Res Cardiol 100:1-10.
5. Chrousos GP and Gold PW (1992) The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. J Am Med Assoc 267:1244-1252.
6. Cohen-Armon M and Sokolovsky M (1991) Depolarization-induced changes in the muscarinic receptor in rat brain and heart are mediated by pertussis-toxin-sensitive G-proteins. J Biol Chem 266:2595-2605.
7. Dessy C, Kelly RA, Balligand JL, and Feron O (2000) Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO (Eur Mol Biol Organ) J 19:4272-4280.
8. Frayne J, Ingram C, Love S, and Hall L (1999) Localisation of phosphatidylethanolamine-binding protein in the brain and other tissues of the rat. Cell Tissue Res 298:415-423.
9. Fu M, Matoba M, Liang QM, Sjogren KG, and Hjalmarson A (1994) Properties of G-protein modulated receptor-adenylyl cyclase system in myocardium of spontaneously hypertensive rats treated with Adriamycin. Int J Cardiol 144:9-18.
10. Gattuso A, Mazza R, Pellegrino D, and Tota B (1999) Endocardial endothelium mediates luminal ACh-NO signaling in isolated frog heart. Am J Physiol 1276:H633-H641.
11. Georget M, Mateo P, Vandecasteele G, Lipskaia L, Defer N, Hanoune J, Hoerter J, Lugnier C, and Fischmeister R (2003) Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). FASEB J 17:1380-1391.
12. Goumon Y, Angelone T, Schoentgen F, Chasserot-Golaz S, Almas B, Fukami MM, Langley K, Welters ID, Tota B, Aunis D, et al. (2004) The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J Biol Chem 279:13054-13064.
13. iα proteins increases arrhythmogenic effects of β-adrenergic stimulation in the heart. J Mol Cell Cardiol 30:1917-1928.
14. Hengst U, Albrecht H, Hess D, and Monard D (2001) The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem 276:535-540.
15. Hove-Madsen L, Mery PF, Jurevicius J, Skeberdis AV, and Fischmeister R (1996) Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91:1-8.
16. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, and Halestrap AP (2000) Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360-369.
17. Katada E, Mitake S, Matsukawa N, Otsuka Y, Tsugu Y, Fujimori O, and Ojika K (1996) Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats. Histochem Cell Biol 105:43-51.
18. Keller ET, Fu Z, and Brennan M (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 68:1049-1053.
19. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, Bickel PE, Andersen JS, Fernandez MM, Bunkenborg J, et al. (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 1:213-222.
20. Kroslak T, Koch T, Kahl E, and Hollt V (2001) Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling. J Biol Chem 276:39772-39778.
21. o-proteins in failing human myocardium. J Mol Cell Cardiol 35:1241-1249.
22. Ojika K and Appel SH (1984) Neurotrophic effects of hippocampal extracts on medial septal nucleus in vitro. Proc Natl Acad Sci USA 81:2567-2571.
23. Ojika K, Mitake S, Kamiya N, Kosuge N, and Taiji M (1994) Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner. Dev Brain Res 79:1-9.
24. Ojika K, Mitake S, Tohdoh N, Appel SH, Otsuka Y, Katada E, and Matsukawa N (2000) Hippocampal cholinergic neurostimulating peptides (HCNP). Prog Neurobiol 60:37-83.
25. Perry AC, Hall L, Bell AE, and Jones R (1994) Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochem J 301:235-242.
26. Raab W (1963) Neurogenic multifocal destruction of myocardial tissue (pathogenic mechanism and its prevention). Rev Can Biol 22:217-239.
27. Schoentgen F and Jolles P (1995) From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site. FEBS Lett 369:22-26.
28. Tan LB, Burniston JG, Clark WA, Ng Y, and Goldspink DF (2003) Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol 41:518-525.
29. Teerlink JR, Pfeffer JM, and Pfeffer MA (1994) Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75:105-113.
30. Tsugu Y, Ojika K, Matsukawa N, Iwase T, Otsuka Y, Katada E, and Mitake S (1998) High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur J Neurol 5:561-569.
31. Vallèe BS, Coadou G, Labbè H, Sy D, Novelle F, and Schoentgen F (2003) Peptide corresponding to the N- and C-terminal parts of PEBP are well-structurated in solution: new insights into their possible interaction with partners in vivo. J Pept Res 61:47-57.
32. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et al. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature (Lond) 401:173-177.